Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0240
-0.0060 (-20.00%)
Aug 21, 2026, 1:38 PM EST
Emmaus Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 15.53 | 12.45 | 16.65 | 29.6 | 18.39 | 20.61 | |
Revenue Growth | 10.98% | -25.22% | -43.73% | 60.94% | -10.77% | -11.04% |
Cost of Revenue | 0.99 | 0.86 | 1.2 | 1.34 | 2.59 | 3.31 |
Gross Profit | 14.54 | 11.6 | 15.45 | 28.26 | 15.8 | 17.3 |
Selling, General & Admin | 9.75 | 11.05 | 16.69 | 23.53 | 20.66 | 19.32 |
Research & Development | 0.24 | 0.31 | 0.66 | 1.19 | 1.73 | 4.11 |
Operating Expenses | 9.99 | 11.37 | 17.35 | 24.72 | 22.39 | 23.43 |
Operating Income | 4.55 | 0.23 | -1.89 | 3.54 | -6.59 | -6.13 |
Interest Expense | -7.92 | -7.13 | -5.49 | -7.38 | -5.01 | -3.1 |
Interest & Investment Income | 0.27 | 0.27 | 0.28 | 0.68 | 0.68 | 0.76 |
Earnings From Equity Investments | - | - | - | -1.71 | -1.91 | -2.73 |
Currency Exchange Gain (Loss) | -0.08 | 0.03 | -0.15 | -1.77 | -2.66 | -2.02 |
Other Non Operating Income (Expenses) | -0.03 | 0.16 | 0.35 | 3.97 | 5.56 | -2.34 |
EBT Excluding Unusual Items | -3.21 | -6.45 | -6.91 | -2.67 | -9.93 | -15.56 |
Gain (Loss) on Sale of Investments | -1.15 | -0.53 | -0.54 | -0.3 | -0.13 | - |
Other Unusual Items | -1.06 | -0.5 | 1.03 | -0.82 | -0.5 | -0.37 |
Pretax Income | -5.43 | -7.48 | -6.42 | -3.79 | -10.57 | -15.92 |
Income Tax Expense | 0.6 | 0.01 | 0.03 | -0.06 | 0.06 | 0.03 |
Net Income | -6.02 | -7.49 | -6.45 | -3.73 | -10.63 | -15.95 |
Net Income to Common | -6.02 | -7.49 | -6.45 | -3.73 | -10.63 | -15.95 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 67 | 64 | 63 | 53 | 49 | 49 |
Shares Outstanding (Diluted) | 67 | 64 | 63 | 53 | 49 | 49 |
Shares Change | 5.22% | 1.27% | 19.07% | 7.41% | 0.38% | 0.73% |
EPS (Basic) | -0.09 | -0.12 | -0.10 | -0.07 | -0.21 | -0.32 |
EPS (Diluted) | -0.10 | -0.12 | -0.10 | -0.07 | -0.21 | -0.32 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 3.97 | -0.01 | -2.3 | -1.52 | -5.1 | -1.33 |
Free Cash Flow Per Share | 0.06 | - | -0.04 | -0.03 | -0.10 | -0.03 |
Gross Margin | 93.60% | 93.12% | 92.79% | 95.47% | 85.93% | 83.93% |
Operating Margin | 29.29% | 1.85% | -11.37% | 11.96% | -35.81% | -29.73% |
Profit Margin | -38.78% | -60.16% | -38.75% | -12.61% | -57.78% | -77.37% |
Free Cash Flow Margin | 25.53% | -0.10% | -13.80% | -5.14% | -27.73% | -6.44% |
EBITDA | 4.61 | 0.27 | -1.87 | 3.57 | -6.53 | -6.07 |
EBITDA Margin | 29.67% | 2.17% | -11.24% | 12.07% | -35.52% | -29.45% |
D&A For EBITDA | 0.06 | 0.04 | 0.02 | 0.03 | 0.05 | 0.06 |
EBIT | 4.55 | 0.23 | -1.89 | 3.54 | -6.59 | -6.13 |
EBIT Margin | 29.29% | 1.85% | -11.37% | 11.96% | -35.81% | -29.73% |